Neurodegenerative diseases / l tyrosin

Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

Throughout this application various patent and nonpatent publications are referenced, full citations of which are provided. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to

Bsk receptor-like tyrosine kinase

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION This invention is in the field of the neurotrophic receptors and their ligands. More specifically this invention relates to the receptor-like tyrosine kinase Bsk and its corresponding ligand and to therapeutic and diagnostic applications which employ the Bsk receptor or

Treating neural disease with tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND Neurodegenerative diseases include genetic and sporadic disorders associated with progressive nervous system dysfunction. It has been estimated that one of four Americans will develop a neurodegenerative condition in their lifetimes. Generally, however, the underlying mechanisms causing

Treating neural disease with tyrosine kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND Neurodegenerative diseases include genetic and sporadic disorders associated with progressive nervous system dysfunction. It has been estimated that one of four Americans will develop a neurodegenerative condition in their lifetimes. Generally, however, the underlying mechanisms causing

Protein tyrosine phosphatase inhibitors and methods of use thereof

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

Protein tyrosine phosphatase inhibitors and methods of use thereof

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

Peptides for use in the topical treatment of retinal neurodegenerative diseases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to the field of medical approaches for ocular diseases that may lead to partial or total blindness. The invention provides useful tools to be applied topically into the eyes, including peptides and analogs of these peptides. BACKGROUND ART Retinal neurodegenerative

Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION The present invention relates to a complex comprising the neurotrophic factors: nerve growth factor (NGF) and trk-proto-oncogene receptor protein. The present invention also relates to methods for detecting the presence of NGF ligand, and trk-proto-oncogene receptor

TRK tyrosine kinase receptor is the physiological receptor for nerve growth factor

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION The present invention relates to a complex comprising the neurotrophic factors: nerve growth factor (NGF) and trk-proto-oncogene receptor protein. The present invention also relates to methods for detecting the presence of NGF ligand, and trk-proto-oncogene receptor

Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

FIELD OF THE INVENTION The invention described herein relates to methods of preventing or treating disorders in patients suffering from the effects of neuronal degeneration. The invention is based in part on the discovery that activation of the c-ret receptor is necessary for neuronal cell

Vector system

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to a vector system. In particular, the present invention relates to a lentiviral vector system for the treatment of Parkinson's disease. BACKGROUND Parkinson's Disease Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of the

Substituted carboxylic acids

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of diabetes. More specifically, it relates to such compounds that are capable of inhibiting Protein tyrosine

Pyrazolo[4,3-D]pyrimidines as kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to novel compounds that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety

Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to novel compounds that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety

Kinase inhibitors

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

The present invention relates to novel compounds that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety

neurodegenerative diseases/l tyrosin

Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases

Bsk receptor-like tyrosine kinase

Treating neural disease with tyrosine kinase inhibitors

Treating neural disease with tyrosine kinase inhibitors

Protein tyrosine phosphatase inhibitors and methods of use thereof

Protein tyrosine phosphatase inhibitors and methods of use thereof

Peptides for use in the topical treatment of retinal neurodegenerative diseases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role

Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor

TRK tyrosine kinase receptor is the physiological receptor for nerve growth factor

Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase

Vector system

Substituted carboxylic acids

Pyrazolo[4,3-D]pyrimidines as kinase inhibitors

Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors

Kinase inhibitors

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird